BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 16264326)

  • 21. WASP-WIP complex in the molecular pathogenesis of Wiskott-Aldrich syndrome.
    Sasahara Y
    Pediatr Int; 2016 Jan; 58(1):4-7. PubMed ID: 26331277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retrovirus-mediated WASP gene transfer corrects Wiskott-Aldrich syndrome T-cell dysfunction.
    Wada T; Jagadeesh GJ; Nelson DL; Candotti F
    Hum Gene Ther; 2002 Jun; 13(9):1039-46. PubMed ID: 12067437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Wiskott-Aldrich syndrome; an x-linked primary immunodeficiency disease with unique and characteristic features.
    Ariga T
    Allergol Int; 2012 Jun; 61(2):183-9. PubMed ID: 22361515
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mixed chimera status of 12 patients with Wiskott-Aldrich syndrome (WAS) after hematopoietic stem cell transplantation: evaluation by flow cytometric analysis of intracellular WAS protein expression.
    Yamaguchi K; Ariga T; Yamada M; Nelson DL; Kobayashi R; Kobayashi C; Noguchi Y; Ito Y; Katamura K; Nagatoshi Y; Kondo S; Katoh H; Sakiyama Y
    Blood; 2002 Aug; 100(4):1208-14. PubMed ID: 12149199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Defects in T-cell-mediated immunity to influenza virus in murine Wiskott-Aldrich syndrome are corrected by oncoretroviral vector-mediated gene transfer into repopulating hematopoietic cells.
    Strom TS; Turner SJ; Andreansky S; Liu H; Doherty PC; Srivastava DK; Cunningham JM; Nienhuis AW
    Blood; 2003 Nov; 102(9):3108-16. PubMed ID: 12855574
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lentiviral vector-mediated gene transfer in T cells from Wiskott-Aldrich syndrome patients leads to functional correction.
    Dupré L; Trifari S; Follenzi A; Marangoni F; Lain de Lera T; Bernad A; Martino S; Tsuchiya S; Bordignon C; Naldini L; Aiuti A; Roncarolo MG
    Mol Ther; 2004 Nov; 10(5):903-15. PubMed ID: 15509508
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Wiskott-Aldrich syndrome: diagnosis, clinical and laboratory manifestations, and treatment.
    Ochs HD; Filipovich AH; Veys P; Cowan MJ; Kapoor N
    Biol Blood Marrow Transplant; 2009 Jan; 15(1 Suppl):84-90. PubMed ID: 19147084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Wiskott-Aldrich syndrome/X-linked thrombocytopenia: WASP gene mutations, protein expression, and phenotype.
    Zhu Q; Watanabe C; Liu T; Hollenbaugh D; Blaese RM; Kanner SB; Aruffo A; Ochs HD
    Blood; 1997 Oct; 90(7):2680-9. PubMed ID: 9326235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical, Laboratory Features and Clinical Courses of Patients with Wiskott Aldrich Syndrome and X-linked Thrombocytopenia-A single center study.
    Bildik HN; Cagdas D; Ozturk Kura A; Oskay Halacli S; Sanal O; Tezcan I
    Immunol Invest; 2022 Jul; 51(5):1272-1283. PubMed ID: 34098853
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure and function of the Wiskott-Aldrich syndrome protein.
    Ochs HD; Notarangelo LD
    Curr Opin Hematol; 2005 Jul; 12(4):284-91. PubMed ID: 15928485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of WASP mutations, mutation hotspots and genotype-phenotype disparities in 24 patients with the Wiskott-Aldrich syndrome.
    Greer WL; Shehabeldin A; Schulman J; Junker A; Siminovitch KA
    Hum Genet; 1996 Dec; 98(6):685-90. PubMed ID: 8931701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Wiskott-Aldrich syndrome iPS cells produce megakaryocytes with defects in cytoskeletal rearrangement and proplatelet formation.
    Ingrungruanglert P; Amarinthnukrowh P; Rungsiwiwut R; Maneesri-le Grand S; Sosothikul D; Suphapeetiporn K; Israsena N; Shotelersuk V
    Thromb Haemost; 2015 Apr; 113(4):792-805. PubMed ID: 25518736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retroviral WASP gene transfer into human hematopoietic stem cells reconstitutes the actin cytoskeleton in myeloid progeny cells differentiated in vitro.
    Dewey RA; Avedillo Díez I; Ballmaier M; Filipovich A; Greil J; Güngör T; Happel C; Maschan A; Noyan F; Pannicke U; Schwarz K; Snapper S; Welte K; Klein C
    Exp Hematol; 2006 Sep; 34(9):1161-9. PubMed ID: 16939809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current and emerging treatment options for Wiskott-Aldrich syndrome.
    Worth AJ; Thrasher AJ
    Expert Rev Clin Immunol; 2015; 11(9):1015-32. PubMed ID: 26159751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeted gene correction of human hematopoietic stem cells for the treatment of Wiskott - Aldrich Syndrome.
    Rai R; Romito M; Rivers E; Turchiano G; Blattner G; Vetharoy W; Ladon D; Andrieux G; Zhang F; Zinicola M; Leon-Rico D; Santilli G; Thrasher AJ; Cavazza A
    Nat Commun; 2020 Aug; 11(1):4034. PubMed ID: 32788576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of human Wiskott-Aldrich syndrome protein in patients' cells leads to partial correction of a phenotypic abnormality of cell surface glycoproteins.
    Huang MM; Tsuboi S; Wong A; Yu XJ; Oh-Eda M; Derry JM; Francke U; Fukuda M; Weinberg KI; Kohn DB
    Gene Ther; 2000 Feb; 7(4):314-20. PubMed ID: 10694812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Identification of two novel WASP gene mutations in 3 boys with Wiskott-Aldrich syndrome].
    Jiang LP; Xu YH; Yang XQ; Liu EM; Wang LJ; Lau YL; Chan KW
    Zhonghua Er Ke Za Zhi; 2003 Aug; 41(8):590-3. PubMed ID: 14744380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Molecular pathogenesis of Wiskott-Aldrich syndrome].
    Sasahara Y; Tsuchiya S
    Nihon Rinsho Meneki Gakkai Kaishi; 2005 Jun; 28(3):140-7. PubMed ID: 15997177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phenotypic and genotypic correction of WASP gene mutation in Wiskott-Aldrich syndrome by unrelated cord blood stem cell transplantation.
    Lee YH; Lim YJ; Shin SA; Song CH; Jo EK; Jung JA; Lee HB
    J Korean Med Sci; 2009 Aug; 24(4):751-4. PubMed ID: 19654965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Wiskott Aldrich Syndrome: A Multi-Institutional Experience From India.
    Suri D; Rikhi R; Jindal AK; Rawat A; Sudhakar M; Vignesh P; Gupta A; Kaur A; Sharma J; Ahluwalia J; Bhatia P; Khadwal A; Raj R; Uppuluri R; Desai M; Taur P; Pandrowala AA; Gowri V; Madkaikar MR; Lashkari HP; Bhattad S; Kumar H; Verma S; Imai K; Nonoyama S; Ohara O; Chan KW; Lee PP; Lau YL; Singh S
    Front Immunol; 2021; 12():627651. PubMed ID: 33936041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.